Practical approaches to the management of autosomal dominant polycystic kidney disease patients in the era of tolvaptan.
Roman-Ulrich MüllerChristian S HaasJohn Andrew SayerPublished in: Clinical kidney journal (2017)
These cases provide a discussion for the use of tolvaptan in ADPKD within the nephrology clinic and allow insights into the practicalities of using this therapy outside of clinical trials.